Institutional members access full text with Ovid®

Share this article on:

Wnt3a Reestablishes Osteogenic Capacity to Bone Grafts from Aged Animals

Leucht, Philipp MD; Jiang, Jie PhD; Cheng, Du BS; Liu, Bo DDS, PhD; Dhamdhere, Girija PhD; Fang, Mark Yang BS; Monica, Stefanie D. BS; Urena, Jonathan J. BS; Cole, Whitney BS; Smith, Lane R. PhD; Castillo, Alesha B. PhD; Longaker, Michael T. MD, MBA; Helms, Jill A. DDS, PhD

Journal of Bone & Joint Surgery - American Volume: 17 July 2013 - Volume 95 - Issue 14 - p 1278–1288
doi: 10.2106/JBJS.L.01502
Scientific Articles
Supplementary Content
Disclosures

Background: Age-related fatty degeneration of the bone marrow contributes to delayed fracture-healing and osteoporosis-related fractures in the elderly. The mechanisms underlying this fatty change are unknown, but they may relate to the level of Wnt signaling within the aged marrow cavity.

Methods: Transgenic mice were used in conjunction with a syngeneic bone-graft model to follow the fates of cells involved in the engraftment. Immunohistochemistry along with quantitative assays were used to evaluate Wnt signaling and adipogenic and osteogenic gene expression in bone grafts from young and aged mice. Liposomal Wnt3a protein (L-Wnt3a) was tested for its ability to restore osteogenic potential to aged bone grafts in critical-size defect models created in mice and in rabbits. Radiography, microquantitative computed tomography (micro-CT) reconstruction, histology, and histomorphometric measurements were used to quantify bone-healing resulting from L-Wnt3a or a control substance (liposomal phosphate-buffered saline solution [L-PBS]).

Results: Expression profiling of cells in a bone graft demonstrated a shift away from an osteogenic gene profile and toward an adipogenic one with age. This age-related adipogenic shift was accompanied by a significant reduction (p < 0.05) in Wnt signaling and a loss in osteogenic potential. In both large and small animal models, osteogenic competence was restored to aged bone grafts by a brief incubation with the stem-cell factor Wnt3a. In addition, liposomal Wnt3a significantly reduced cell death in the bone graft, resulting in significantly more osseous regenerate in comparison with controls.

Conclusions: Liposomal Wnt3a enhances cell survival and reestablishes the osteogenic capacity of bone grafts from aged animals.

Clinical Relevance: We developed an effective, clinically applicable, regenerative medicine-based strategy for revitalizing bone grafts from aged patients.

1Department of Orthopaedic Surgery (P.L., L.R.S.), Stanford School of Medicine, Stanford, CA 94305

2Department of Bioengineering (J.J.), University of California Los Angeles, Los Angeles, CA 90095

3Division of Plastic and Reconstructive Surgery (D.C., B.L., G.D., M.Y.F., M.T.L., J.A.H.), Department of Surgery Stanford School of Medicine, Stanford, CA 94305. E-mail address for J.A. Helms: jhelms@stanford.edu

4Department of Molecular and Cell Biology (S.D.M.), University of California at Berkeley, Berkeley, CA 94720

5Department of Medicine (J.J.U.), Columbia University College of Physicians and Surgeons, New York, NY 10032

6Center for Tissue Regeneration, Repair, and Restoration (W.C., A.B.C.), Rehabilitation Research and Development, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304

* Philipp Leucht, MD, Jie Jiang, PhD, Du Cheng, BS, and Bo Liu, DDS, PhD contributed equally to the preparation of this article.

Copyright 2013 by The Journal of Bone and Joint Surgery, Incorporated
You currently do not have access to this article

To access this article: